The provision of a CCE (Colon Capsule Endoscopy), delivery, reading and reporting service

NHSScotland is looking identify an Innovation Partner who will develop an innovative CCE (Colon Capsule Endoscopy) managed service

integrated into the NHS across Scotland with the aim of improving the patient journey, improving outcomes and reducing the requirement

for traditional hospital-based optical colonoscopy procedures.

Innovation Partner who will perform CCE (Colon Capsule Endoscopy), delivery, reading and reporting service including all, or some of the

following components:

-Patient preparation: - critical for a clean and timely video and outcome

-Inform the patient, setting appointment, managing consent

-Provide patient with preparation medication and guidelines

-Assess patient’s ability to be well prepared

-Procedure delivery: - managed delivery with structured approach -

-Meet the patient in their community (home, primary care centre, other health service centre)

-Re-assessing ability to conduct successful procedure

-Support the patient in correct placement of belt & recorder

-Support the patient with capsule ingestion and dealing with potential adverse events

-Assist remotely when needed

-Receive returned equipment, uploading of video, managing equipment

-Video analysis: - timely, save and efficient delivery of report –

-Receive (de-identified) patient video

-Pre-read the video

-Validate findings

-Create comprehensive report

-Transmit report electronically to referring consultant

In addition, in regards to IT integration, the service will be able to seamlessly refer a patient to a video capsule endoscopy and receive the

report the same way as any other endoscopy report. This includes scheduling of follow-ups as well as integration into patient records such

as SCIStore and with Trakcare. Users of alternative endoscopy management systems could be connected into the NHS IT infrastructure.

It will also provide a dedicated portal is available for additional status reporting and other information for patients, care takers and

consultants.

The proposed Innovation Partnership will consist of two distinct phases.

Phase 1 consists of a circa 500 patient trial which will determine the clinical and economical viability of this innovative service.

Following completion of Phase 1 the Authority will either: terminate the agreement; extend into Phase 2 with no change to the agreement;

re-negotiate a number of points with the Innovation Partner and enter into Phase 2.

Any renegotiation of the contract following phase 1 will be in line with Regulation 72 of The Public Contracts (Scotland) Regulations

2015.

Phase 2 will see the widespread adoption of the service across NHS Scotland. Additional information: It is envisaged that one (1) Innovation Partner will be awarded the contract.

Please note, the contract value given in this Contract Notice is an indicative figure. Given this is a new innovative approach the final value

of the contract could vary substantially.